Cargando…

A multi‐biomarker follow‐up study of patients with multiple sclerosis

OBJECTIVES: This study aimed to examine the levels of the macrophage marker sCD163 and other biomarkers at the time of diagnosis of patients with either clinically isolated syndrome (CIS) or relapsing‐remitting multiple sclerosis (RRMS), and assess relation to clinical indicators of prognosis, disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stilund, Morten, Gjelstrup, Mikkel Carstensen, Christensen, Tove, Møller, Holger Jon, Petersen, Thor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036432/ https://www.ncbi.nlm.nih.gov/pubmed/27688939 http://dx.doi.org/10.1002/brb3.509

Ejemplares similares

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
por: Stilund, Morten, et al.
Publicado: (2015)

Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis
por: Gjelstrup, Mikkel Carstensen, et al.
Publicado: (2017)

Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis
por: Carstensen, Mikkel, et al.
Publicado: (2020)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

Pathogenesis of multiple sclerosis: expression of HERV-Fc1: a human endogenous retrovirus
por: Laska, Magdalena Janina, et al.
Publicado: (2011)

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity
por: Brudek, Tomasz, et al.
Publicado: (2009)

Absence of xenotropic murine leukaemia virus-related virus in Danish patients with multiple sclerosis
por: Maric, Romana, et al.
Publicado: (2011)

Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES)
por: Riemenschneider, Morten, et al.
Publicado: (2021)

Expression of HERV-H/W env epitopes on PBMCs from MS patients with active disease
por: Brudek, Tomasz, et al.
Publicado: (2011)

Biomarkers in Multiple Sclerosis: An Up-to-Date Overview
por: Katsavos, Serafeim, et al.
Publicado: (2013)

The Course of Self-Efficacy for Therapeutic Use of Self in Norwegian Occupational Therapy Students: A 10-Month Follow-Up Study
por: Schwank, Kathrin, et al.
Publicado: (2018)

Follow-up of hypertension in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad
Publicado: (2016)

Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up
por: Londoño, Ana C., et al.
Publicado: (2016)

Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2020)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Quality of life in multiple sclerosis: The differential impact of motor and cognitive fatigue
por: David Ruban, Sabina, et al.
Publicado: (2021)

Predictors of students’ participation in a learning environment survey with annual follow-ups
por: DaLomba, Elaina, et al.
Publicado: (2021)

Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
por: Petersen, Thor, et al.
Publicado: (2011)

Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression
por: Sharma, Priyanka, et al.
Publicado: (2012)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

The Etiology of Multiple Sclerosis: Genetic Evidence for the Involvement of the Human Endogenous Retrovirus HERV-Fc1
por: Nexø, Bjørn A., et al.
Publicado: (2011)

Background, design and conceptual model of the cluster randomized multiple-component workplace study: FRamed Intervention to Decrease Occupational Muscle pain - "FRIDOM"
por: Christensen, Jeanette Reffstrup, et al.
Publicado: (2016)

Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines
por: Natarajan, Renuka, et al.
Publicado: (2015)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Molecular biomarkers in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Digital Biomarkers in Multiple Sclerosis
por: Dillenseger, Anja, et al.
Publicado: (2021)

Protein biomarkers in multiple sclerosis
por: Kim, Jun-Soon
Publicado: (2023)

Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2021)

Cognitive trajectories in multiple sclerosis: a long-term follow-up study
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset
por: Yperman, Jan, et al.
Publicado: (2022)

Aerobic Capacity Is Not Associated with Most Cognitive Domains in Patients with Multiple Sclerosis—A Cross-Sectional Investigation
por: Langeskov-Christensen, Martin, et al.
Publicado: (2018)

Endogenous retroviruses and multiple sclerosis–new pieces to the puzzle
por: Nissen, Kari K, et al.
Publicado: (2013)

A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis
por: Hamidi, Vida, et al.
Publicado: (2018)

Restriction Genes for Retroviruses Influence the Risk of Multiple Sclerosis
por: Nexø, Bjørn A., et al.
Publicado: (2013)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Biomarkers in Multiple Sclerosis: Role of Antibodies
por: Berger, Thomas, et al.
Publicado: (2006)

Chemokine Receptors as Biomarkers in Multiple Sclerosis
por: Fox, Robert J., et al.
Publicado: (2006)

Inflammasome Proteins As Biomarkers of Multiple Sclerosis
por: Keane, Robert W., et al.
Publicado: (2018)

Biomarkers of multiple sclerosis: current findings
por: Harris, Violaine K, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7uj4f5m8bi7s6abuq67pgsgtnq